Unicycive Therapeutics, Inc. (UNCY) SEC Filings — 2026
5 SEC filings for Unicycive Therapeutics, Inc. (UNCY) in 2026.
Filings
- Unicycive Therapeutics Files Annual Report — ARS · Apr 30, 2026
- Unicycive Therapeutics Files Definitive Proxy Materials — DEFA14A · Apr 30, 2026
- Unicycive Therapeutics, Inc. 8-K Filing — 8-K · Apr 6, 2026
- Unicycive Therapeutics Files 8-K with Financial Updates — 8-K · Mar 30, 2026
- Unicycive Resubmits Key Kidney Drug NDA, Eyes June 2026 FDA Decision — 10-K · Mar 30, 2026